恶病质-话题@MedSci

#恶病质#

15篇内容 | 1687人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2089453, encodeId=31ee208945333, content=该研究发现<a href='/topic/show?id=e1616844395' target=_blank style='color:#2F92EE;'>#环境微生物#</a>、<a href='/topic/show?id=6ebc81e3482' target=_blank style='color:#2F92EE;'>#肠道菌群#</a>、肾脏IMD-NF-κB免疫反应和<a href='/topic/show?id=24af4e552a1' target=_blank style='color:#2F92EE;'>#尿酸#</a>代谢是<a href='/topic/show?id=3ce252932f0' target=_blank style='color:#2F92EE;'>#恶性肿瘤#</a>导致机体死亡的重要因素，且独立于目前已知的肿瘤相关的机体消耗，为深入理解肿瘤-宿主互作、实现荷瘤生存提供了新的角度。鉴于生物体在自然界中不可避免地接触外在环境，因此外界微生物、肠道菌群、肾脏免疫反应和尿酸代谢实属 “房间里的大象”（图2），会在肿瘤以及其他疾病发生发展中发挥重要的作用。<a href='/topic/show?id=f07d529e6ca' target=_blank style='color:#2F92EE;'>#恶病质#</a>#<a href='/topic/show?id=d8dbe130197' target=_blank style='color:#2F92EE;'>#癌症#</a>, objectTitle=Immunity：武汉大学揭示癌症恶液质的致病机理：肠道-肾脏免疫轴和尿酸代谢, objectType=article, longId=737225, objectId=b8f1e3722576, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20220823/d959ddc2437241ab8f4e2e03f620ee43.jpg, objectUrl=/article/show_article.do?id=b8f1e3722576, replyNumber=1, likeNumber=293, createdTime=2022-09-21, rootId=0, userName=小小医者, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8f1e3722576, moduleTitle=Immunity：武汉大学揭示癌症恶液质的致病机理：肠道-肾脏免疫轴和尿酸代谢, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8f1e3722576)], followStatus=false, userIsMember=false, type=1, lengthMark=1), GetTopicListResponse(id=2227157, encodeId=ef04222e15758, content=<a href='/topic/show?id=f07d529e6ca' target=_blank style='color:#2F92EE;'>#恶病质#</a> <a href='/topic/show?id=3953e13547f' target=_blank style='color:#2F92EE;'>#癌症恶病质#</a> <a href='/topic/show?id=e49611930039' target=_blank style='color:#2F92EE;'>#ponsegromab#</a>, objectTitle=NEJM：重大突破! ponsegromab能显著抑制肿瘤患者恶病质, objectType=article, longId=844398, objectId=93c48443982b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20240920/c0773bc20647494586cdb90f04fe10e1-QzxSC4wJaYhC.jpg, objectUrl=/article/show_article.do?id=93c48443982b, replyNumber=0, likeNumber=31, createdTime=2024-09-23, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=93c48443982b, moduleTitle=NEJM：重大突破! ponsegromab能显著抑制肿瘤患者恶病质, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93c48443982b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2226746, encodeId=959e2226e46a3, content=<a href='/topic/show?id=f07d529e6ca' target=_blank style='color:#2F92EE;'>#恶病质#</a> <a href='/topic/show?id=b6b011e87899' target=_blank style='color:#2F92EE;'>#ESMO 2024#</a> <a href='/topic/show?id=e49611930039' target=_blank style='color:#2F92EE;'>#ponsegromab#</a>, objectTitle=让癌症患者“胖起来”！NEJM：创新靶向疗法解决癌症重要“死因”, objectType=article, longId=843916, objectId=94f8843916b0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240920/1726797596079_8538692.jpg, objectUrl=/article/show_article.do?id=94f8843916b0, replyNumber=0, likeNumber=50, createdTime=2024-09-20, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=94f8843916b0, moduleTitle=让癌症患者“胖起来”！NEJM：创新靶向疗法解决癌症重要“死因”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=94f8843916b0)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2186781, encodeId=fabc2186e81af, content=<a href='/topic/show?id=d8dbe130197' target=_blank style='color:#2F92EE;'>#癌症#</a> <a href='/topic/show?id=61f58810966' target=_blank style='color:#2F92EE;'>#营养#</a> <a href='/topic/show?id=f07d529e6ca' target=_blank style='color:#2F92EE;'>#恶病质#</a> <a href='/topic/show?id=e9f91110e999' target=_blank style='color:#2F92EE;'>#mCONUT评分#</a>, objectTitle=Nutrition：mCONUT评分能全面反映营养、免疫和炎症，精准预测癌症恶病质生存, objectType=article, longId=812961, objectId=d3f0812961b2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20240131/db5e723359ff43efb68af7c65cf42ef8.jpg, objectUrl=/article/show_article.do?id=d3f0812961b2, replyNumber=0, likeNumber=114, createdTime=2024-02-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=d3f0812961b2, moduleTitle=Nutrition：mCONUT评分能全面反映营养、免疫和炎症，精准预测癌症恶病质生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3f0812961b2)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2117671, encodeId=9fee211e67178, content=成人<a href='/topic/show?id=d8dbe130197' target=_blank style='color:#2F92EE;'>#癌症#</a><a href='/topic/show?id=f07d529e6ca' target=_blank style='color:#2F92EE;'>#恶病质#</a>的<a href='/topic/show?id=30f7e5923cd' target=_blank style='color:#2F92EE;'>#筛查#</a>评估与干预治疗, objectTitle=成人癌症恶病质的筛查评估与干预治疗——基于《成人癌症恶病质：ESMO临床实践指南》解读, objectType=guider, longId=22329, objectId=798771c0029690bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=798771c0029690bf, replyNumber=0, likeNumber=162, createdTime=2023-03-05, rootId=0, userName=lifestar, userId=aa0e14, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=798771c0029690bf, moduleTitle=成人癌症恶病质的筛查评估与干预治疗——基于《成人癌症恶病质：ESMO临床实践指南》解读, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=798771c0029690bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1693095, encodeId=7cb016930957d, content=<a href='/topic/show?id=f07d529e6ca' target=_blank style='color:#2F92EE;'>#恶病质#</a>, objectTitle=2022 ASCO：恶病质对广泛期小细胞肺癌患者一线免疫治疗疗效的影响, objectType=article, longId=728259, objectId=88dde28259a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88dde28259a8, replyNumber=0, likeNumber=99, createdTime=2022-07-31, rootId=0, userName=wincls, userId=3cd929335736, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88dde28259a8, moduleTitle=2022 ASCO：恶病质对广泛期小细胞肺癌患者一线免疫治疗疗效的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88dde28259a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1693094, encodeId=10061693094b1, content=<a href='/topic/show?id=f07d529e6ca' target=_blank style='color:#2F92EE;'>#恶病质#</a>, objectTitle=CGH:恶病质在肝细胞癌患者中普遍存在并与更差的预后相关, objectType=article, longId=726393, objectId=1de8e26393ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1de8e26393ac, replyNumber=0, likeNumber=107, createdTime=2022-09-27, rootId=0, userName=wincls, userId=3cd929335736, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1de8e26393ac, moduleTitle=CGH:恶病质在肝细胞癌患者中普遍存在并与更差的预后相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1de8e26393ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2089454, encodeId=1bf32089454a7, content=<a href='/topic/show?id=fb429e8302c' target=_blank style='color:#2F92EE;'>#阿拉莫林#</a>阿拉莫林用于晚期<a href='/topic/show?id=2493130e1a1' target=_blank style='color:#2F92EE;'>#NSCLC#</a>患者癌症<a href='/topic/show?id=32483698286' target=_blank style='color:#2F92EE;'>#厌食#</a>-<a href='/topic/show?id=e96b529e45a' target=_blank style='color:#2F92EE;'>#恶液质#</a>是否安全？<a href='/topic/show?id=f07d529e6ca' target=_blank style='color:#2F92EE;'>#恶病质#</a>，目前阿拉莫林是重要的热点, objectTitle=Ann Oncol:阿拉莫林用于晚期NSCLC患者癌症厌食-恶液质是否安全？, objectType=article, longId=113490, objectId=09491134908c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/webeditor/uploadfile/201709/20170920162158349.jpg, objectUrl=/article/show_article.do?id=09491134908c, replyNumber=0, likeNumber=168, createdTime=2022-09-21, rootId=0, userName=小小医者, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=09491134908c, moduleTitle=Ann Oncol:阿拉莫林用于晚期NSCLC患者癌症厌食-恶液质是否安全？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=09491134908c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2089451, encodeId=888220894510d, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a><a href='/topic/show?id=e96b529e45a' target=_blank style='color:#2F92EE;'>#恶液质#</a>，也称为<a href='/topic/show?id=f07d529e6ca' target=_blank style='color:#2F92EE;'>#恶病质#</a>，表现为极度消瘦，皮包骨头，贫血、无力，完全卧床，生活不能自理，全身衰竭，极度痛苦。, objectTitle=Biochem J：肿瘤恶液质的治疗：靶向、营养和锻炼, objectType=article, longId=116682, objectId=38b5116682e5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/webeditor/uploadfile/201710/20171018132821996_s.png, objectUrl=/article/show_article.do?id=38b5116682e5, replyNumber=0, likeNumber=128, createdTime=2022-09-21, rootId=0, userName=小小医者, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38b5116682e5, moduleTitle=Biochem J：肿瘤恶液质的治疗：靶向、营养和锻炼, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=38b5116682e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1693092, encodeId=bd5e169309235, content=<a href='/topic/show?id=f07d529e6ca' target=_blank style='color:#2F92EE;'>#恶病质#</a>, objectTitle=Clinical Nutrition：皮下而非内脏脂肪组织是胃癌恶病质患者预后的标志物, objectType=article, longId=217776, objectId=0d3321e776ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d3321e776ed, replyNumber=0, likeNumber=102, createdTime=2022-08-19, rootId=0, userName=wincls, userId=3cd929335736, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d3321e776ed, moduleTitle=Clinical Nutrition：皮下而非内脏脂肪组织是胃癌恶病质患者预后的标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0d3321e776ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1693093, encodeId=de271693093bc, content=<a href='/topic/show?id=f07d529e6ca' target=_blank style='color:#2F92EE;'>#恶病质#</a>, objectTitle=2020年ASCO-SITC：恶病质与接受Pembrolizumab的晚期肺癌患者的生存率相关, objectType=article, longId=221034, objectId=5e2522103406, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e2522103406, replyNumber=0, likeNumber=97, createdTime=2022-08-06, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e2522103406, moduleTitle=2020年ASCO-SITC：恶病质与接受Pembrolizumab的晚期肺癌患者的生存率相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e2522103406)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1693091, encodeId=44d41693091af, content=<a href='/topic/show?id=f07d529e6ca' target=_blank style='color:#2F92EE;'>#恶病质#</a>, objectTitle=2020年ASCO-SITC：恶病质与接受Pembrolizumab的晚期肺癌患者的生存率相关, objectType=article, longId=187720, objectId=ddb118e72078, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ddb118e72078, replyNumber=0, likeNumber=175, createdTime=2020-06-02, rootId=0, userName=wincls, userId=3cd929335736, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ddb118e72078, moduleTitle=2020年ASCO-SITC：恶病质与接受Pembrolizumab的晚期肺癌患者的生存率相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ddb118e72078)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1693090, encodeId=4c75169309052, content=<a href='/topic/show?id=f07d529e6ca' target=_blank style='color:#2F92EE;'>#恶病质#</a>, objectTitle=Int J Cancer：研究发现lncRNA CAAlnc1调控癌性恶病质脂肪丢失的功能及作用机制, objectType=article, longId=164937, objectId=4b4416493ea8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b4416493ea8, replyNumber=0, likeNumber=95, createdTime=2019-12-24, rootId=0, userName=wincls, userId=3cd929335736, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b4416493ea8, moduleTitle=Int J Cancer：研究发现lncRNA CAAlnc1调控癌性恶病质脂肪丢失的功能及作用机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4b4416493ea8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1693089, encodeId=3144169308963, content=<a href='/topic/show?id=f07d529e6ca' target=_blank style='color:#2F92EE;'>#恶病质#</a>, objectTitle=2019 HFSA共识声明：心衰患者的营养，肥胖和恶病质, objectType=article, longId=163526, objectId=c27116352630, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c27116352630, replyNumber=0, likeNumber=0, createdTime=2019-06-16, rootId=0, userName=wincls, userId=3cd929335736, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c27116352630, moduleTitle=2019 HFSA共识声明：心衰患者的营养，肥胖和恶病质, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c27116352630)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1693088, encodeId=2a841693088ef, content=<a href='/topic/show?id=f07d529e6ca' target=_blank style='color:#2F92EE;'>#恶病质#</a>, objectTitle=一文掌握癌症恶病质的诊疗, objectType=article, longId=84176, objectId=917d841e6d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=917d841e6d7, replyNumber=0, likeNumber=101, createdTime=2017-04-21, rootId=0, userName=wincls, userId=3cd929335736, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=917d841e6d7, moduleTitle=一文掌握癌症恶病质的诊疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=917d841e6d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1693087, encodeId=ec00169308ee2, content=<a href='/topic/show?id=f07d529e6ca' target=_blank style='color:#2F92EE;'>#恶病质#</a>, objectTitle=Developmental Cell：胰岛素干扰触发癌症恶病质, objectType=article, longId=49101, objectId=6cf3491010f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6cf3491010f, replyNumber=0, likeNumber=99, createdTime=2016-03-16, rootId=0, userName=wincls, userId=3cd929335736, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6cf3491010f, moduleTitle=Developmental Cell：胰岛素干扰触发癌症恶病质, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6cf3491010f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1693086, encodeId=e9b11693086b9, content=<a href='/topic/show?id=f07d529e6ca' target=_blank style='color:#2F92EE;'>#恶病质#</a>, objectTitle=Nature：甲状旁腺激素相关蛋白(PTHrP)可能是癌症恶病质的重要原因, objectType=article, longId=37890, objectId=41853e8905e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41853e8905e, replyNumber=0, likeNumber=99, createdTime=2014-12-28, rootId=0, userName=wincls, userId=3cd929335736, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41853e8905e, moduleTitle=Nature：甲状旁腺激素相关蛋白(PTHrP)可能是癌症恶病质的重要原因, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41853e8905e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1693085, encodeId=3b251693085fa, content=<a href='/topic/show?id=f07d529e6ca' target=_blank style='color:#2F92EE;'>#恶病质#</a>, objectTitle=JACC：右心室功能不全常共存心源性恶病质, objectType=article, longId=22761, objectId=074322e61a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=074322e61a4, replyNumber=0, likeNumber=91, createdTime=2013-09-13, rootId=0, userName=wincls, userId=3cd929335736, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=074322e61a4, moduleTitle=JACC：右心室功能不全常共存心源性恶病质, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=074322e61a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

恶病质

2020-05-29

小小医者 (审核中...)

前往app查看评论内容

全文收起该研究发现#环境微生物#、#肠道菌群#、肾脏IMD-NF-κB免疫反应和#尿酸#代谢是#恶性肿瘤#导致机体死亡的重要因素，且独立于目前已知的肿瘤相关的机体消耗，为深入理解肿瘤-宿主互作、实现荷瘤生存提供了新的角度。鉴于生物体在自然界中不可避免地接触外在环境，因此外界微生物、肠道菌群、肾脏免疫反应和尿酸代谢实属 “房间里的大象”（图2），会在肿瘤以及其他疾病发生发展中发挥重要的作用。#恶病质###癌症#

Immunity：武汉大学揭示癌症恶液质的致病机理：肠道-肾脏免疫轴和尿酸代谢

2022-09-21

梅斯管理员 (审核中...)

前往app查看评论内容

#恶病质# #癌症恶病质# #ponsegromab#

NEJM：重大突破! ponsegromab能显著抑制肿瘤患者恶病质

2024-09-23发表于威斯康星

梅斯管理员 (审核中...)

前往app查看评论内容

#恶病质# #ESMO 2024# #ponsegromab#

让癌症患者“胖起来”！NEJM：创新靶向疗法解决癌症重要“死因”

2024-09-20发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#癌症# #营养# #恶病质# #mCONUT评分#

Nutrition：mCONUT评分能全面反映营养、免疫和炎症，精准预测癌症恶病质生存

2024-02-10发表于威斯康星

lifestar (审核中...)

前往app查看评论内容

成人#癌症##恶病质#的#筛查#评估与干预治疗

成人癌症恶病质的筛查评估与干预治疗——基于《成人癌症恶病质：ESMO临床实践指南》解读

2023-03-05发表于上海

wincls (审核中...)

前往app查看评论内容

#恶病质#

2022 ASCO：恶病质对广泛期小细胞肺癌患者一线免疫治疗疗效的影响

2022-07-31

wincls (审核中...)

前往app查看评论内容

#恶病质#

CGH:恶病质在肝细胞癌患者中普遍存在并与更差的预后相关

2022-09-27

小小医者 (审核中...)

前往app查看评论内容

#阿拉莫林#阿拉莫林用于晚期#NSCLC#患者癌症#厌食#-#恶液质#是否安全？#恶病质#，目前阿拉莫林是重要的热点

Ann Oncol:阿拉莫林用于晚期NSCLC患者癌症厌食-恶液质是否安全？

2022-09-21

小小医者 (审核中...)

前往app查看评论内容

#肿瘤##恶液质#，也称为#恶病质#，表现为极度消瘦，皮包骨头，贫血、无力，完全卧床，生活不能自理，全身衰竭，极度痛苦。

Biochem J：肿瘤恶液质的治疗：靶向、营养和锻炼

2022-09-21

wincls (审核中...)

前往app查看评论内容

#恶病质#

Clinical Nutrition：皮下而非内脏脂肪组织是胃癌恶病质患者预后的标志物

2022-08-19

hb2008ye (审核中...)

前往app查看评论内容

#恶病质#

2020年ASCO-SITC：恶病质与接受Pembrolizumab的晚期肺癌患者的生存率相关

2022-08-06

wincls (审核中...)

前往app查看评论内容

#恶病质#

2020年ASCO-SITC：恶病质与接受Pembrolizumab的晚期肺癌患者的生存率相关

2020-06-02

wincls (审核中...)

前往app查看评论内容

#恶病质#

Int J Cancer：研究发现lncRNA CAAlnc1调控癌性恶病质脂肪丢失的功能及作用机制

2019-12-24

wincls (审核中...)

前往app查看评论内容

#恶病质#

2019 HFSA共识声明：心衰患者的营养，肥胖和恶病质

2019-06-16

wincls (审核中...)

前往app查看评论内容

#恶病质#

一文掌握癌症恶病质的诊疗

2017-04-21

wincls (审核中...)

前往app查看评论内容

#恶病质#

Developmental Cell：胰岛素干扰触发癌症恶病质

2016-03-16

wincls (审核中...)

前往app查看评论内容

#恶病质#

Nature：甲状旁腺激素相关蛋白(PTHrP)可能是癌症恶病质的重要原因

2014-12-28

wincls (审核中...)

前往app查看评论内容

#恶病质#

JACC：右心室功能不全常共存心源性恶病质

2013-09-13

科室
- - 订阅+
  - 更多科室
工具
服务